Abstract
Arterial stiffness is a risk factor for cardiovascular disease. Transforming growth factor β1 is a pleiotropic cytokine, with many functions, including influence on the vascular wall (e.g., on angiogenesis, endothelial cells and the extracellular matrix). We investigated five functional polymorphisms in the transforming growth factor β1 gene (−800 G/A, −509 C/T, codon 10 Leu/Pro, codon 25 Arg/Pro and codon 263 Thr/Ile) in relation to arterial stiffness in a population-based study. A total of 3863 participants of the Rotterdam Study, a prospective population-based study, were included in the current study. The relations of the genotypes and haplotypes with arterial stiffness (pulse wave velocity (PWV), distensibility coefficient (DC) and pulse pressure (PP)) were studied using analyses of variance and linear regression. The analyses were adjusted for age, sex, mean arterial pressure, heart rate, conventional cardiovascular risk factors and measures of atherosclerosis. There were no associations between PWV and −800 G/A (P=0.56), −509 C/T (P=0.29), codon 10 (P=0.98) and, codon 25 (P=0.28). These polymorphisms were not associated with the DC or with PP. The haplotype-based analyses yielded similar results. The results of this study show that the TGF-β1 –800 G/A, −509 C/T, codon 10 Leu/Pro and codon 25 Arg/Pro polymorphisms are not associated with arterial stiffness.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O’Rourke MF . Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation 1983; 68: 50–58.
Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–1918.
Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M et al. Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens 1994; 7: 1076–1084.
London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int 1990; 37: 137–142.
Wada T, Kodaira K, Fujishiro K, Maie K, Tsukiyama E, Fukumoto T et al. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler Thromb 1994; 14: 479–482.
van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454–460.
Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10–15.
Franklin SS, Khan SA, Wong ND, Larson MG, Levy D . Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation 1999; 100: 354–360.
Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657–663.
Sayed-Tabatabaei FA, van Rijn MJ, Schut AF, Aulchenko YS, Croes EA, Zillikens MC et al. Heritability of the function and structure of the arterial wall: findings of the Erasmus Rucphen Family (ERF) study. Stroke 2005; 36: 2351–2356.
Massague J . The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597–641.
Border WA, Noble NA . Transforming growth factor beta in tissue fibrosis. New Engl J Med 1994; 331: 1286–1292.
Robertson AK, Rudling M, Zhou X, Gorelik L, Flavell RA, Hansson GK . Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest 2003; 112: 1342–1350.
Mallat Z, Tedgui A . The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr Opin Lipidol 2002; 13: 523–529.
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986; 83: 4167–4171.
Grainger DJ, Metcalfe JC . A pivotal role for TGF-beta in atherogenesis? Biol Rev Camb Philos Soc 1995; 70: 571–596.
Topper JN . TGF-beta in the cardiovascular system: molecular mechanisms of a context-specific growth factor. Trends Cardiovasc Med 2000; 10: 132–137.
Saltis J, Agrotis A, Bobik A . Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease. Clin Exp Pharmacol Physiol 1996; 23: 193–200.
Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D’Amore PA . Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 1999; 84: 298–305.
Hirschi KK, Rohovsky SA, D’Amore PA . PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805–814.
Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN et al. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 1998; 95: 6983–6988.
Jacob T, Hingorani A, Ascher E . Overexpression of transforming growth factor-beta1 correlates with increased synthesis of nitric oxide synthase in varicose veins. J Vasc Surg 2005; 41: 523–530.
Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–887.
Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93–97.
Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (London) 1998; 95: 659–667.
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA . Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991; 7: 403–422.
Hoeks AP, Brands PJ, Smeets FA, Reneman RS . Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990; 16: 121–128.
Kool MJ, van Merode T, Reneman RS, Hoeks AP, Struyker Boudier HA, Van Bortel LM . Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res 1994; 28: 610–614.
Reneman RS, van Merode T, Hick P, Muytjens AM, Hoeks AP . Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol 1986; 12: 465–471.
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183–1197.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE . Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432–1437.
Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994; 343: 504–507.
Waddell TK, Dart AM, Medley TL, Cameron JD, Kingwell BA . Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension 2001; 38: 927–931.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.
Acknowledgements
This study was supported by NWO (Netherlands Organization for Scientific Research) under Grant no. 904-61-196 and under the ASPASIA Grant no. 015.000.090, by the Center for Medical Systems Biology and by the European Commission under grant QLK6-CT-2002-02629 (GENOMOS).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sie, M., Mattace-Raso, F., Uitterlinden, A. et al. TGF-β1 polymorphisms and arterial stiffness; the Rotterdam Study. J Hum Hypertens 21, 431–437 (2007). https://doi.org/10.1038/sj.jhh.1002175
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002175
Keywords
This article is cited by
-
A Review of Genetics, Arterial Stiffness, and Blood Pressure in African Americans
Journal of Cardiovascular Translational Research (2012)
-
Association between transforming growth factor β1 polymorphisms and atrial fibrillation in essential hypertensive subjects
Journal of Biomedical Science (2010)
-
Arterial stiffness in hypertensives in relation to expression of angiopoietin-1 and 2 genes in peripheral monocytes
Journal of Human Hypertension (2010)
-
Association between transforming growth factor β1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects
Molecular and Cellular Biochemistry (2010)
-
Arterial stiffness: beyond pulse wave velocity and its measurement
Journal of Human Hypertension (2008)